VK

Vandana Khasesaheb Kharade

Active Director Director DIN 10981579
DIN 10981579 First appointment Mar 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Vandana Khasesaheb Kharade

Data last updated:

Vandana Khasesaheb Kharade is a Director at Galaxia Lifesciences Private Limited (since 2025). The company operates in Pharma.

DIN 10981579
Primary Designation Director
Industry Pharma
First Appointment 03 Mar 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Galaxia Lifesciences Private Limited U46497MH2025PTC441888
Director03 Mar 20252025Active

Board colleagues of Vandana Khasesaheb Kharade

NameDINCompanyDesignation
Sagar Bhagwan Teli10005621Galaxia Lifesciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Galaxia Lifesciences Private Limited
Premium access

Shareholding and investment profile for Vandana Khasesaheb Kharade

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vandana Khasesaheb Kharade

Vandana Khasesaheb Kharade currently holds 1 directorship: Galaxia Lifesciences Private Limited (Director, since 03 Mar 2025).

Vandana Khasesaheb Kharade was first appointed on 03 Mar 2025 as Director at Galaxia Lifesciences Private Limited.

The current boards of Vandana Khasesaheb Kharade's companies include Sagar Bhagwan Teli (Galaxia Lifesciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available